This course uses a faux product to introduce essential concepts of Patient Centricity including a comprehensive description of strategy.
Last month, Medical Affairs and clinical experts from six organizations came together to help make clinical trials more accessible to and better understood by people facing vitiligo. You can do this in your therapeutic area.
MAPS speaks with MyHealthTeams Cofounder and CEO, Eric Peacock, about how health communities can help the biopharmaceutical industry develop new products that truly make a difference in patients’ lives.
This session provides a learning opportunity for our audience by providing background on FDA’s Offices of Minority Health and Health Equity, and Women’s Health
At the end of this series of podcasts, the participant should be able to discuss the functions and activities of key internal partners and identify potential areas for compliant collaboration by MSLs with key internal partners.
In this episode of Partnering for Today and Tomorrow we discuss the functions and activities of key internal partners and how we identify potential areas for compliant collaboration by MSLs with key internal partners.
The webinar will provide a snapshot of insights on what matters to patients and how pharma fares in terms of patient centricity based on a new patient centricity benchmarking survey piloted in 2019.
Join this session to understand aligned HCP and patient education activities from the perspective of the current landscape, Medical Affairs support for aligned medical education and risk mitigation ensuring transparency, fairness and lawfulness.
This MAPS podcast describes publication plain-language summaries and how patients find them useful.
Join this session to understand how an effective digital tele-mentoring program builds local capacity in rural and underserved areas by empowering healthcare professionals to treat complex diseases that have historically only been treated by specialists.